NEUROMETRIX INC (NURO) Stock Price & Overview
NASDAQ:NURO • US6412558800
Current stock price
The current stock price of NURO is 4.58 USD. Today NURO is up by 5.05%. In the past month the price increased by 3.6%. In the past year, price increased by 6.51%.
NURO Key Statistics
- Market Cap
- 9.435M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -4.03
- Dividend Yield
- N/A
NURO Stock Performance
NURO Stock Chart
NURO Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to NURO. When comparing the yearly performance of all stocks, NURO is one of the better performing stocks in the market, outperforming 79.56% of all stocks.
NURO Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to NURO. No worries on liquidiy or solvency for NURO as it has an excellent financial health rating, but there are worries on the profitability.
NURO Earnings
NURO Forecast & Estimates
NURO Groups
Sector & Classification
NURO Financial Highlights
Over the last trailing twelve months NURO reported a non-GAAP Earnings per Share(EPS) of -4.03. The EPS decreased by -98.82% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -50.94% | ||
| ROE | -54.54% | ||
| Debt/Equity | 0 |
NURO Ownership
NURO Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.27 | 191.058B | ||
| ISRG | INTUITIVE SURGICAL INC | 47.23 | 171.691B | ||
| SYK | STRYKER CORP | 23.08 | 133.773B | ||
| BSX | BOSTON SCIENTIFIC CORP | 20.36 | 103.561B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.97 | 48.532B | ||
| IDXX | IDEXX LABORATORIES INC | 39.6 | 46.687B | ||
| BDX | BECTON DICKINSON AND CO | 11.86 | 45.635B | ||
| RMD | RESMED INC | 19.02 | 33.595B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14 | 32.892B | ||
| DXCM | DEXCOM INC | 26.48 | 25.532B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.91 | 18.254B | ||
| HOLX | HOLOGIC INC | 15.29 | 16.777B | ||
| PODD | INSULET CORP | 35.65 | 15.816B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About NURO
Company Profile
NeuroMetrix, Inc. engages in the development and manufacture of diagnostic and therapeutic neurostimulation-based medical devices. The company is headquartered in Waltham, Massachusetts and currently employs 13 full-time employees. The company went IPO on 2004-07-22. The firm's products are wearable or hand-held medical devices enabled by proprietary consumables and software solutions that include mobile apps, enterprise software and cloud-based systems. The firm has two commercial brands. Quell is a wearable neuromodulation platform. DPNCheck is a point-of-care screening test for peripheral neuropathy. The company operates two product categories: Diagnostic technology and Therapeutic technology. Diagnostic technology product category is engaged in point-of-care peripheral neuropathy assessment. Therapeutic technology product category is engaged in wearable neuromodulation for chronic pain syndromes. Its patients control and personalize the technology via a mobile phone application, and their utilization and certain clinical metrics may be tracked in the Quell Health Cloud.
Company Info
IPO: 2004-07-22
NEUROMETRIX INC
1000 Winter Street
Waltham MASSACHUSETTS 01801 US
CEO: Shai N. Gozani
Employees: 13
Phone: 17818909989
NEUROMETRIX INC / NURO FAQ
Can you describe the business of NEUROMETRIX INC?
NeuroMetrix, Inc. engages in the development and manufacture of diagnostic and therapeutic neurostimulation-based medical devices. The company is headquartered in Waltham, Massachusetts and currently employs 13 full-time employees. The company went IPO on 2004-07-22. The firm's products are wearable or hand-held medical devices enabled by proprietary consumables and software solutions that include mobile apps, enterprise software and cloud-based systems. The firm has two commercial brands. Quell is a wearable neuromodulation platform. DPNCheck is a point-of-care screening test for peripheral neuropathy. The company operates two product categories: Diagnostic technology and Therapeutic technology. Diagnostic technology product category is engaged in point-of-care peripheral neuropathy assessment. Therapeutic technology product category is engaged in wearable neuromodulation for chronic pain syndromes. Its patients control and personalize the technology via a mobile phone application, and their utilization and certain clinical metrics may be tracked in the Quell Health Cloud.
Can you provide the latest stock price for NEUROMETRIX INC?
The current stock price of NURO is 4.58 USD. The price increased by 5.05% in the last trading session.
Does NURO stock pay dividends?
NURO does not pay a dividend.
What is the ChartMill technical and fundamental rating of NURO stock?
NURO has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the market capitalization of NURO stock?
NEUROMETRIX INC (NURO) has a market capitalization of 9.43M USD. This makes NURO a Nano Cap stock.
Who owns NEUROMETRIX INC?
You can find the ownership structure of NEUROMETRIX INC (NURO) on the Ownership tab.